Hemorheological modifications induced by heparinic therapy: Capillary blood viscosity, erythrocyte deformability, aggregation index;Modificazioni emoreologiche indotte dalla terapia eparinica: Viscosita ematica capillare, deformabilita eritrocitaria, indice di aggregazione

Minerva Cardioangiologica

Volumn 47, Issue 4, 1999, Pages 95-119

  Achilli, E ^a   Cortinovis, A ^a   Ardemagni, P ^a   Crippa, A ^a,b  

^a UNIVERSITY OF PAVIA   (Italy)

^b NONE   (Italy)

Author keywords

Capillary blood viscosity; Erythrocyte aggregation; Erythrocyte deformability; Heparin; Thrombosis

Indexed keywords

HEPARIN CALCIUM;

ADULT; ARTICLE; BLOOD CLOTTING; BLOOD FILTRATION; BLOOD RHEOLOGY; BLOOD VISCOSITY; CAPILLARY BLOOD; CLINICAL ARTICLE; CONTROLLED STUDY; ERYTHROCYTE AGGREGATION; ERYTHROCYTE DEFORMABILITY; FEMALE; HEPARINIZATION; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; MALE; MICROCIRCULATION; NORMAL HUMAN; PERIPHERAL OCCLUSIVE ARTERY DISEASE; RISK FACTOR; THROMBOSIS;

ANTICOAGULANTS; BLOOD VISCOSITY; CAPILLARIES; ERYTHROCYTE AGGREGATION; HEPARIN; HUMANS; MICROCIRCULATION; PLETHYSMOGRAPHY, IMPEDANCE; RHEOLOGY; THROMBOSIS;

EID: 0033053642     PISSN: 00264725     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Agosti R, Marletta F. Simposio in medicina clinica: Trombosi e antitrombosi: introduzione. Osp Magg 1997;91(3):192.
2. Bauer KA, Rosenberg RD. The pathophisiology of the pre-thrombotic state in humans: insight gained from studies using markers of hemostatic system activation. Blood 1987;70:343-50.
3. Manucci PM, Tripodi A. Stati di ipercoagulabilità. Meccanismi, marcatori e gestione dei pazienti. Osp Magg 1997;91(3):193-8.
4. Marietta F, Agosti R, Dorini S, Paleari B. Il ruolo dell'emoreologia nella fisiologia clinica della trombosi. Osp Mag 1997:91(3):213-21.
5. Dintenfass L. Tixotropy of blood and proneness in thrombus formation. Circ Res 19625;3:123.
6. Surgenor DM. The blood red cells. Acad Press 1975:2.
7. Dintenfass L. Consideration on the internal viscosity of red cells and its effect on the viscosity of whole blood. Angiology 1962;13:333.
8. Prothero J, Burthon AC. La fisica del flusso capillare. Biophis J 1961;1:566-79.
9. Agosti R, Clivati A, D'Ettore M. Hematocrit dependence of erythrocyte aggregation. Clin Hemorheol 1988; 8:603-20.
10. Jan KM. Roles of surface electrochemistry and macro-molecular adsorption in heparin-induced red blood cell aggregation. Biorheology 1986;23(2):91-8.
11. Agosti R, Somazzi R, Narsrawi F. Emoreologia leucocitaria. XXIX Convegno nazionale di studi SIITS-ACIT, Cernobbio (CO), 1994.
12. Longhini E, Agosti R, Cherubini P. Haemorheology in hypertension. Clin Hemorheol 1986;6:567-76.
13. Cherubini P, Bozzoni M, Agosti R. Red blood cells filtrability in essential hypertension: role of transmembranary ion fluxes. Clin Hemorheol 1989;9:89-100.
14. Clivati A, Marazzini L, Agosti R. Effect of hematocrit on the blood viscosity of patients with cronic respiratory failure and secondary polycytemia. Respiration 1981;42:168-74.
15. Marazzini L, Soroldoni M, Clivati A. Effect of isovolumetric venesection on blond viscosity on red blood cell deformability, and on arterial flow velocity in chronic respiratory failure with secondary polycythemia. Respiration 1981;42:168-74.
16. Longhini E, Agosti R, Clivati A. L'apprioccio terapeutico della poliglobulia secondaria. Osp Mag 1990;85: 281-5.
17. Maruzzi MM, Scapellato L, Agosti R. Detection of plasma fibrinogen level in patient with lung cancer. 3rd Congress of European Society of Pneumology. Basel 1985.
18. Poggio M, Agosti R, Scapellato L. Plasma fibrinogen level and erythrocyte aggregation in patients with lung cancer. 4th European Conference on clinical Hemorrheology. Siena, 1985.
19. Cavestri R, Radice L, Ferrarini F. Influence of blood theology on cerebral blood flow in normal subjects. J Cereb Blood Flow Metab 1989;9:614.
20. Cavestri R, Pelucchi A, Mastropasqua B. Effects of isovolemic hemolution in acute cerebral ischemia. Clin Hemotheol 1986;6:381 -94.
21. Clivati A, Biffi E, Agosti R. Hemorrheology in acute myocardial infarction. 4th European Conference on Clinical Hemorheology. Siena, 1985.
22. Chesebro HJ, Badimon JJ, Ortiz AF, Meyer BJ, Fuster V. Conjiuntive antithrombotic therapy for thrombolysis in miocardial infarction. Am J Cardiol 1993;72:66-74.
23. Stein B, Fuster V, Halperin JL, Chesebro HJ. Antithrombotic therapy in cardiac disease. An emerging approach based on payhogenesis and risk. Circulation, 1989;80:1501-13.
24. O'Reilly BG. Farmaci delle affezioni della coagulazione. In: Katzung BG. Farmacologia generale e clinica. III edizione. Padova: Piccin, 1992:436-46.
25. Heras M, Chesebro HJ, Penny WJ. Effects of thrombin inhibition on the development of acute platelet-thrombus deposition during angioplasaty in pigs: heparin versus recombinant hirudin, a specific thrombin inhibitor. Circulation, 1989;79:657-65.
26. Walton PL, Ricketts CR, Bangham DR. Heterogeneity of heparin. Br J Haemat 1966;12:310-25
27. Majerus PW, Broze GJ, Miletich JP, Tollefsen DM. Anticoagulant, thromholytic and antiplatelet drugs. In: Goodman Gilman A, Rail TW, Nies AS, Taylor P. The pharmacological pasis of therapeutics. VIII edition, New York: Pergamon Press, 1990:1313-7.
28. Davis HL. Heparin is an anionic hydrated anticoagulant. Adv Exp Med Biol 1975;52:131-7.
29. Meda A, Alberto S, Cologno PG, Uslenghi E. Effetto reologico dell'eparina a diverso dosaggio. Boll Soc It Biol Sper 1965;41(18):1100-4.
30. Wells REJ, Denton R, Menus EW. Measurement of viscosity of biologic fluids by come plate viscosimeter. J Lab Clin Med 1961;57:646-56.
31. Larcan A, Streiff F, Peters A, Genetet B. Action de l'hé parine sur la viscosité sanguine. Med Pharmacol Exp 1965;13:289-93.
32. cortinovis A, Crippa A, Santoro E, Nobili D, Pedroni G. Variasioni della viscosità plasmatica ed ematica e della deformabililà ed aggregazione eritrocitaria in presenza di varie soluzioni anticoagulanti. Medical Praxis, 1984:5(2):1-21.
33. Cortinovis A, Crippa A, Santoro E, Nobili D, Pedroni G. Caratteristiche degli eritrociti in presenza di anticoagulantt-conservanti di uso trasfusionale. Medical Praxis, 1984;5(2):67-80.
34. Kameneva MV, Antaki JF, Watach MJ, Borovetz HS, Kormos RL. Heparin effect on red blood cell aggregation. Biorheology, 1994;31(3):297-304.
35. Reid HL, Barnes AJ, Lock PJ, Dormandy JA, Dormandy TL. A simple method for measuring erythrocyte deformability. Clin Pathol 1976;29:855-8.
36. Pearson TC. Rheology of absolute polycythaemias. Clin Hemorheo, 1987;1:637.
37. Cortinovis A, Crippa A, Sciacca V, Caravaggio V. Presentazione di un metodo di interpretazione della deformabilità eritrocitaria. Minerva Med 1988;79(5): 343-8.